Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 1
2008 1
2010 2
2011 2
2014 1
2015 3
2016 1
2017 1
2018 1
2019 3
2020 1
2021 7
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Improving diagnostic delays in bipolar disorders in clinical practice.
Szmulewicz A, Quiroz D, Padilla E, Girala N, Igoa A, Caravotta P, Valerio MP, Smith J, Reale ML, Strejilevich SA. Szmulewicz A, et al. Among authors: padilla e. Bipolar Disord. 2019 Nov;21(7):666-669. doi: 10.1111/bdi.12827. Epub 2019 Sep 11. Bipolar Disord. 2019. PMID: 31491052 No abstract available.
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa.
Puig-Collderram B, Domene-Ochoa S, Salvà-Comas M, Montero MM, Duran X, González JR, Grau S, Oliver A, Horcajada JP, Padilla E, Segura C, Prim N. Puig-Collderram B, et al. Among authors: padilla e. Microbiol Spectr. 2022 Aug 31;10(4):e0065122. doi: 10.1128/spectrum.00651-22. Epub 2022 Jul 25. Microbiol Spectr. 2022. PMID: 35876574 Free PMC article.
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
Montero MM, Domene-Ochoa S, López-Causapé C, López-Montesinos I, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Ferrer Alapont L, Grau S, Oliver A, Horcajada JP. Montero MM, et al. Among authors: padilla e. Microbiol Spectr. 2022 Jun 29;10(3):e0089222. doi: 10.1128/spectrum.00892-22. Epub 2022 Jun 13. Microbiol Spectr. 2022. PMID: 35695526 Free PMC article.
Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine.
Arias-Cabrales C, Folgueiras M, Faura A, Eguia J, Padilla E, Hurtado S, Ribera L, Echeverria-Esnal D, Pérez-Sáez MJ, Redondo-Pachón D, Burballa C, Buxeda A, Llinàs-Mallol L, Cao H, Barbosa F, Rovira X, Cima F, Pascual J, Crespo M. Arias-Cabrales C, et al. Among authors: padilla e. Transplantation. 2023 Feb 1;107(2):457-465. doi: 10.1097/TP.0000000000004433. Epub 2022 Nov 2. Transplantation. 2023. PMID: 36584381 Free PMC article.
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring.
Crespo M, Barrilado-Jackson A, Padilla E, Eguía J, Echeverria-Esnal D, Cao H, Faura A, Folgueiras M, Solà-Porta E, Pascual S, Barbosa F, Hurtado S, Ribera L, Río-No L, Pérez-Sáez MJ, Redondo-Pachón D, Pascual J. Crespo M, et al. Among authors: padilla e. Am J Transplant. 2022 Mar;22(3):786-800. doi: 10.1111/ajt.16854. Epub 2021 Oct 7. Am J Transplant. 2022. PMID: 34551187 Free PMC article.
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model.
Montero MM, Domene-Ochoa S, López-Causapé C, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Ferrer-Alapont L, Angulo-Brunet A, Grau S, Oliver A, Horcajada JP. Montero MM, et al. Among authors: padilla e. Sci Rep. 2021 Nov 12;11(1):22178. doi: 10.1038/s41598-021-01784-4. Sci Rep. 2021. PMID: 34773066 Free PMC article.
35 results